scripod.com

Amanda Feilding: Let’s talk psychedelics

In this episode, Dua Lipa speaks with Amanda Feilding, a lifelong advocate for drug policy reform and psychedelic research. They explore the history, science, and societal impact of substances like LSD and psilocybin, from their ancient indigenous roots to their modern potential for treating mental health conditions.
Amanda Feilding shares her personal journey with psychedelics, beginning with her early experiments with cannabis and LSD in the 1960s, including a traumatic high-dose incident. She discusses her controversial self-performed trepanation, an ancient practice she believes can restore energy, and her subsequent shift from art to science to legitimize psychedelic research. Feilding criticizes the criminalization and Schedule 1 status of these substances, arguing they are non-toxic and hold immense therapeutic potential for depression, anxiety, and addiction. She highlights her Beckley Foundation's research showing psilocybin's ability to quiet the brain's default mode network and cites a remarkable case where microdosing LSD revived a 97-year-old Alzheimer's patient. The conversation concludes with Feilding recommending key resources for further learning, emphasizing the urgent need for funding and open-minded exploration of these powerful tools.
02:44
02:44
Psychedelics have deep indigenous roots in human cultural evolution.
10:11
10:11
A major societal shift in perception of psychedelics has occurred only in the last few years.
14:37
14:37
Trepanation allows the brain membrane to expand.
27:37
27:37
A microdose revived a 97-year-old Alzheimer's patient from vegetative apathy.
31:50
31:50
Psychedelics have potential benefits that need research funding